Skip to content

Efficacy and safety of repeated intense pulsed light and intradermal injection of hyaluronic acid

Efficacy and safety of repeated intense pulsed light and intradermal injection of hyaluronic acid

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081659
Enrollment
Unknown
Registered
2024-03-07
Start date
2023-02-17
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy people

Interventions

IPL group:With repeated pulsed light treatment treatment once a month for 3 times.
HA group:With repeated intradermal injection of hyaluronic acid treatment once a month for 3 times.

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Voluntarily participate in the experiment and sign the informed consent; Consent to conduct the trial as directed by a physician throughout the study period; Chinese female subjects aged 18-40 years.

Exclusion criteria

Exclusion criteria: Did not fill in the informed consent and can not accurately describe the condition; Female subjects who are pregnant, breastfeeding or planning to become pregnant; People who have facial skin disorders that may affect the judgment of the experimental results; Subjects with known infection at the site to be treated; Have serious heart, liver, kidney damage and serious immune dysfunction; Subjects who are participating in clinical trials of other drugs or medical devices; Other subjects assessed by the investigator as unsuitable for participation in the study.

Design outcomes

Primary

MeasureTime frame
Water content of stratum corneum;Transepidermal Water Loss;Skin color;

Secondary

MeasureTime frame
Stratum corneum thickness;epidermal thickness;Skin lipid content;Skin elasticity;pH;Cuticle surface roughness;

Countries

China

Contacts

Public ContactWu Yan

Peking University First Hospital

3437477565@qq.com+86 10 8357 3274

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026